Skip to main content
. 2023 Mar 29;28(7):3044–3054. doi: 10.1038/s41380-023-02037-8

Fig. 5. Clinical studies of healthy subjects and patients diagnosed with BD and MDD.

Fig. 5

a–e The representative protein bands of p-GSK3β, GSK3β, p-cPLA2, cPLA2, and β-actin from the plasma of healthy subjects and the patients of BD and MDD, and their grey values of protein brands normalised to β-actin. f Levels of AA in the plasma of healthy subjects and BD and MDD patients. g Levels of PGE2 in the plasma of healthy subjects and patients of BD and MDD. Data were presented as mean ± SD, n = 30 per group. One-way ANOVA for comparisons including more than two groups; unpaired two-tailed t-test for two group comparisons. Significant different from control group: *p < 0.05, **p < 0.01 and ***p < 0.001.